Suzetrigine
VX21-548-103
Phase 2 small_molecule completed
Quick answer
Suzetrigine for Diabetic Peripheral Neuropathy is a Phase 2 program (small_molecule) at VERTEX PHARMACEUTICALS INC / MA with 1 ClinicalTrials.gov record(s).
Program details
- Company
- VERTEX PHARMACEUTICALS INC / MA
- Indication
- Diabetic Peripheral Neuropathy
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed